BRPI0513702B8 - formas de dosagem e métodos para produção das mesmas - Google Patents

formas de dosagem e métodos para produção das mesmas

Info

Publication number
BRPI0513702B8
BRPI0513702B8 BRPI0513702A BRPI0513702A BRPI0513702B8 BR PI0513702 B8 BRPI0513702 B8 BR PI0513702B8 BR PI0513702 A BRPI0513702 A BR PI0513702A BR PI0513702 A BRPI0513702 A BR PI0513702A BR PI0513702 B8 BRPI0513702 B8 BR PI0513702B8
Authority
BR
Brazil
Prior art keywords
producing
methods
dosage forms
coated
relates
Prior art date
Application number
BRPI0513702A
Other languages
English (en)
Inventor
A Rinker Roger
J Casale Nicholas
H Comly James
Pollock Brenda
D Ayer Atul
Geerke Johan
Costello Martin
Wieand Dennis
Parekh Kishor
Original Assignee
Mcneil Ppc Inc
Chenango Zero Llc
Johnson & Johnson Consumer Inc
Chenango Two Llc
Currahee Holding Company Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34960790&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0513702(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mcneil Ppc Inc, Chenango Zero Llc, Johnson & Johnson Consumer Inc, Chenango Two Llc, Currahee Holding Company Inc filed Critical Mcneil Ppc Inc
Publication of BRPI0513702A publication Critical patent/BRPI0513702A/pt
Publication of BRPI0513702B1 publication Critical patent/BRPI0513702B1/pt
Publication of BRPI0513702B8 publication Critical patent/BRPI0513702B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2873—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catalysts (AREA)
  • Gears, Cams (AREA)

Abstract

COMPRIMIDOS REVESTIDOS GELATINOSOS QUE SE DESINTEGRAM RAPIDAMENTE. A presente invenção refere-se a uma forma de dosagem com revestimento gelatinoso aperfeiçoado que apresenta duas regiões finais revestidas com materiais gelatinosos e uma faixa circunferente exposta. São proporcionadas aberturas pelo menos na faixa exposta para revelar o material de núcleo. A invenção também refere-se a métodos para produzir essas formas de dosagem com revestimento gelatinoso.
BRPI0513702A 2004-07-23 2005-02-16 formas de dosagem e métodos para produção das mesmas BRPI0513702B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/898,061 2004-07-23
US10/898,061 US8067029B2 (en) 2004-01-13 2004-07-23 Rapidly disintegrating gelatinous coated tablets
PCT/US2005/001075 WO2006022805A1 (en) 2004-07-23 2005-02-16 Rapidly disintegrating gelatinous coated tablets

Publications (3)

Publication Number Publication Date
BRPI0513702A BRPI0513702A (pt) 2008-05-13
BRPI0513702B1 BRPI0513702B1 (pt) 2020-02-18
BRPI0513702B8 true BRPI0513702B8 (pt) 2022-08-30

Family

ID=34960790

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513702A BRPI0513702B8 (pt) 2004-07-23 2005-02-16 formas de dosagem e métodos para produção das mesmas

Country Status (14)

Country Link
US (1) US8067029B2 (pt)
EP (2) EP1773302B2 (pt)
KR (1) KR101140599B1 (pt)
CN (1) CN1913877B (pt)
AT (1) ATE433319T1 (pt)
BR (1) BRPI0513702B8 (pt)
CA (1) CA2553444C (pt)
DE (1) DE602005014874D1 (pt)
DK (1) DK1773302T3 (pt)
ES (2) ES2420843T5 (pt)
MX (1) MXPA06008307A (pt)
PL (1) PL1773302T3 (pt)
RU (1) RU2367413C2 (pt)
WO (1) WO2006022805A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253312A1 (en) * 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
US8067029B2 (en) † 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US20070009573A1 (en) * 2005-07-07 2007-01-11 L N K International Method of forming immediate release dosage form
EP2066307B1 (en) * 2006-09-15 2012-07-04 Capsugel Belgium NV Rapidly disintegrating dosage form
US20080317678A1 (en) * 2007-06-22 2008-12-25 Szymczak Christopher E Laser Marked Dosage Forms
US20080317677A1 (en) * 2007-06-22 2008-12-25 Szymczak Christopher E Laser Marked Dosage Forms
CA2695451A1 (en) * 2007-08-17 2009-02-26 Bpsi Holdings, Llc Method and arrangement for forming variable color pharmaceutical products
CA2807319C (en) * 2010-08-18 2018-08-14 Mcneil-Ppc, Inc. Tablet sleeve for improved performance
CN103039688B (zh) 2012-01-20 2016-01-06 奥驰亚客户服务公司 口腔用产品
US9854831B2 (en) 2012-01-20 2018-01-02 Altria Client Services Llc Oral product
CN102754908B (zh) * 2012-01-20 2015-06-10 奥驰亚客户服务公司 口腔用烟草产品
CN103040090B (zh) * 2012-01-20 2016-03-30 奥驰亚客户服务公司 脱除烟草的口腔用产品
CN102754907B (zh) 2012-01-20 2015-06-24 奥驰亚客户服务公司 口腔用产品
US9185931B2 (en) 2013-05-13 2015-11-17 Altria Client Services Inc. Oral product
US9839212B2 (en) 2015-04-16 2017-12-12 Bio-Lab, Inc. Multicomponent and multilayer compacted tablets
US10583089B2 (en) 2016-07-19 2020-03-10 Johnson & Johnson Consumer Inc. Tablets having discontinuous coated regions
CN109689030A (zh) 2016-07-19 2019-04-26 强生消费者公司 具有不连续涂覆区域的片剂
CN108354910A (zh) * 2018-05-17 2018-08-03 安士制药（中山）有限公司 一种西甲硅油软胶囊
WO2025193835A1 (en) * 2024-03-13 2025-09-18 Purdue Research Foundation Oxygenation systems and methods for hydroponics

Family Cites Families (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB759081A (en) 1954-04-15 1956-10-10 John Holroyd And Company Ltd Improvements relating to machines for the production of coated tablets and the like
US3185626A (en) 1963-03-06 1965-05-25 Sterling Drug Inc Tablet coating method
US3760804A (en) 1971-01-13 1973-09-25 Alza Corp Improved osmotic dispenser employing magnesium sulphate and magnesium chloride
BE794951A (fr) 1972-02-03 1973-05-29 Parke Davis & Co Conditionnement soluble dans l'eau
GB1497044A (en) 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
US4173626A (en) 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
DE2936040C2 (de) 1979-09-06 1982-05-19 Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring Dragierverfahren und Mittel zur Durchführung des Verfahrens, bestehend im wesentlichen aus Saccharose, wenigstens einem weiteren Zucker und Wasser
US4543370A (en) 1979-11-29 1985-09-24 Colorcon, Inc. Dry edible film coating composition, method and coating form
US4683256A (en) 1980-11-06 1987-07-28 Colorcon, Inc. Dry edible film coating composition, method and coating form
US4449983A (en) 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4576604A (en) 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
US4828841A (en) 1984-07-24 1989-05-09 Colorcon, Inc. Maltodextrin coating
US4643894A (en) 1984-07-24 1987-02-17 Colorcon, Inc. Maltodextrin coating
US4873231A (en) 1986-04-08 1989-10-10 Smith Walton J Decreasing the toxicity of an ibuprofen salt
US4802924A (en) 1986-06-19 1989-02-07 Colorcon, Inc. Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products
IE58401B1 (en) 1986-06-20 1993-09-08 Elan Corp Plc Controlled absorption pharmaceutical composition
US4816262A (en) 1986-08-28 1989-03-28 Universite De Montreal Controlled release tablet
US4966771A (en) 1987-02-20 1990-10-30 Mcneilab, Inc. Gelatin coated caplets and process for making same
US5234099A (en) 1987-02-20 1993-08-10 Mcneil-Ppc, Inc. Coated medicaments and apparatus and methods for making same
US4820524A (en) 1987-02-20 1989-04-11 Mcneilab, Inc. Gelatin coated caplets and process for making same
US4867983A (en) 1987-02-20 1989-09-19 Mcneilab, Inc. Method for double dipping gelating coated caplets
CA1330886C (en) 1988-01-22 1994-07-26 Bend Research Inc. Osmotic system for delivery of dilute solutions
DE3822095A1 (de) 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
GB8820353D0 (en) 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
US4906478A (en) 1988-12-12 1990-03-06 Valentine Enterprises, Inc. Simethicone/calcium silicate composition
US4984240A (en) 1988-12-22 1991-01-08 Codex Corporation Distributed switching architecture for communication module redundancy
US4965089A (en) 1989-04-10 1990-10-23 Sauter Manufacturing Corp. Method and apparatus for the gelatin coating of caplets
NZ233403A (en) 1989-04-28 1992-09-25 Mcneil Ppc Inc Simulated capsule-like medicament
US5146730A (en) 1989-09-20 1992-09-15 Banner Gelatin Products Corp. Film-enrobed unitary-core medicament and the like
US5275822A (en) 1989-10-19 1994-01-04 Valentine Enterprises, Inc. Defoaming composition
US5089270A (en) 1990-05-15 1992-02-18 L. Perrigo Company Capsule-shaped tablet
US5213738A (en) 1990-05-15 1993-05-25 L. Perrigo Company Method for making a capsule-shaped tablet
US5460824A (en) 1990-06-27 1995-10-24 Warner-Lambert Company Method for the preparation of an encapsulated medicament
US5464631A (en) 1990-06-27 1995-11-07 Warner-Lambert Company Encapsulated dosage forms
US5503673A (en) 1990-11-05 1996-04-02 Mcneil-Ppc, Inc Apparatus for dip coating product
US5436026A (en) 1990-11-05 1995-07-25 Mcneil-Ppc, Inc. Discharge and transfer system for apparatus for gelatin coating tablets
US5228916A (en) 1990-11-05 1993-07-20 Mcneil-Ppc, Inc. Apparatus for creating a gelatin coating
US5538125A (en) 1990-11-05 1996-07-23 Mcneil-Ppc, Inc. Indexing and feeding systems for apparatus for gelatin coating tablets
US5114720A (en) 1990-12-27 1992-05-19 American Cyanamid Company Gelatin coated tablets and method for producing same
CA2061520C (en) 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
US5286497A (en) 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
US5326570A (en) 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
WO1993014158A1 (en) 1992-01-17 1993-07-22 Berwind Pharmaceutical Services, Inc. Film coatings and film coating compositions based on cellulosic polymers and lactose
US5427614A (en) 1992-02-14 1995-06-27 Warner-Lambert Company Starch based formulations
US5256440A (en) 1992-06-22 1993-10-26 Merck & Co., Inc. Process for producing a tablet core aperture
US5317849A (en) 1992-08-07 1994-06-07 Sauter Manufacturing Corporation Encapsulation equipment and method
US5415868A (en) 1993-06-09 1995-05-16 L. Perrigo Company Caplets with gelatin cover and process for making same
IT1264855B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
US5498255A (en) 1993-08-17 1996-03-12 Alza Corporation Osmotic device for protracted pulsatile delivery of agent
US6245350B1 (en) 1994-12-16 2001-06-12 Warner-Lambert Company Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
ES2150017T3 (es) 1994-12-16 2000-11-16 Warner Lambert Co Proceso de encapsulacion de comprimidos en una capsula y formas de dosificacion solidas obtenidas por este proceso.
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
US6471994B1 (en) 1995-01-09 2002-10-29 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
US5824338A (en) 1996-08-19 1998-10-20 L. Perrigo Company Caplet and gelatin covering therefor
US6077539A (en) 1996-11-12 2000-06-20 Pozen, Inc. Treatment of migraine headache
US6103260A (en) 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
US5942034A (en) 1997-07-24 1999-08-24 Bayer Corporation Apparatus for the gelatin coating of medicaments
US6110499A (en) 1997-07-24 2000-08-29 Alza Corporation Phenytoin therapy
DE19733505A1 (de) 1997-08-01 1999-02-04 Knoll Ag Schnell wirksames Analgeticum
US6365185B1 (en) 1998-03-26 2002-04-02 University Of Cincinnati Self-destructing, controlled release peroral drug delivery system
FR2781152B1 (fr) 1998-07-20 2001-07-06 Permatec Tech Ag Utilisation d'un polymere de type acrylique en tant qu'agent de desagregation
US20010055613A1 (en) 1998-10-21 2001-12-27 Beth A. Burnside Oral pulsed dose drug delivery system
US6270805B1 (en) 1998-11-06 2001-08-07 Andrx Pharmaceuticals, Inc. Two pellet controlled release formulation for water soluble drugs which contains an alkaline metal stearate
US6274162B1 (en) 2000-01-14 2001-08-14 Bpsi Holdings, Inc. Elegant film coating system
DE19964225C2 (de) 1999-12-17 2002-01-24 Henkel Kgaa Preßverfahren für mehrphasige Formkörper
US6599532B2 (en) 2000-01-13 2003-07-29 Osmotica Corp. Osmotic device containing alprazolam and an antipsychotic agent
GB0002305D0 (en) 2000-02-01 2000-03-22 Phoqus Limited Power material for electrostatic application
US20020028240A1 (en) 2000-04-17 2002-03-07 Toyohiro Sawada Timed-release compression-coated solid composition for oral administration
US7223421B2 (en) 2000-06-30 2007-05-29 Mcneil-Ppc, Inc. Teste masked pharmaceutical particles
US20030086972A1 (en) 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
GB0027471D0 (en) * 2000-11-08 2000-12-27 Smithkline Beecham Plc Processes
US6872405B2 (en) 2001-05-10 2005-03-29 Yamanouchi Pharmaceutical Co., Ltd. Quick-disintegrating tablet in buccal cavity and manufacturing method thereof
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US20030072731A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
GB0120835D0 (en) 2001-08-28 2001-10-17 Smithkline Beecham Plc Process
WO2003018302A1 (en) 2001-08-30 2003-03-06 Sanwa Kagaku Kenkyusho Co., Ltd Device for producing molded articles, and a molded article that can be produced by such device
CA2461616A1 (en) 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US20040253312A1 (en) 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
US6837696B2 (en) 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US6742646B2 (en) 2001-09-28 2004-06-01 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US6767200B2 (en) 2001-09-28 2004-07-27 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US6946156B2 (en) 2002-05-15 2005-09-20 Mcneil-Ppc, Inc. Process for enrobing a core
US7169450B2 (en) 2002-05-15 2007-01-30 Mcneil-Ppc, Inc. Enrobed core
US7429619B2 (en) 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US6902609B2 (en) 2003-02-20 2005-06-07 Bpsi Holdings, Inc. Pearlescent film coating systems and substrates coated therewith
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7879354B2 (en) * 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets

Also Published As

Publication number Publication date
EP1773302A1 (en) 2007-04-18
EP2098224A1 (en) 2009-09-09
EP2098224B2 (en) 2021-08-18
BRPI0513702B1 (pt) 2020-02-18
KR101140599B1 (ko) 2012-07-09
ES2420843T3 (es) 2013-08-27
EP2098224B1 (en) 2013-05-29
US8067029B2 (en) 2011-11-29
BRPI0513702A (pt) 2008-05-13
HK1135615A1 (en) 2010-06-11
CA2553444A1 (en) 2006-03-02
EP1773302B1 (en) 2009-06-10
DE602005014874D1 (de) 2009-07-23
ATE433319T1 (de) 2009-06-15
MXPA06008307A (es) 2007-01-18
ES2420843T5 (es) 2022-03-04
ES2326671T3 (es) 2009-10-16
CN1913877B (zh) 2012-07-18
WO2006022805A1 (en) 2006-03-02
US20050152971A1 (en) 2005-07-14
DK1773302T3 (da) 2009-09-14
EP1773302B2 (en) 2024-06-26
CN1913877A (zh) 2007-02-14
CA2553444C (en) 2013-09-24
PL1773302T3 (pl) 2009-11-30
RU2007102286A (ru) 2008-07-27
RU2367413C2 (ru) 2009-09-20
KR20070036781A (ko) 2007-04-03

Similar Documents

Publication Publication Date Title
BRPI0513702B8 (pt) formas de dosagem e métodos para produção das mesmas
AR058753A1 (es) Uso de composiciones nutricionales con fosfolipidos esfingolipidos y colesterol
AR050254A1 (es) Intermediarios y procesos para preparar dichos intermediarios utiles en la fabricacion de pirrolotriazinas
CL2008001656A1 (es) Anticuerpo anti-c3b; composicion farmaceutica que lo comprende, y su uso para prevenir o tratar un trastorno asociado con el complemento; kit que lo contiene.
BRPI0719641A2 (pt) "película correspondendo pelo menos uma camada, película encolhida, artigo, pacote e processo para preparar uma película compreendendo pelo menos uma camada"
NI200900022A (es) Anticuerpo especifico de prlr y usos del mismo
UY33397A (es) Forma sólida de un naftaleno carboxamida
CR20150102A (es) Anticuerpos que se unen a il-4 y/o il-13 (divisional 2)
CL2008001741A1 (es) Anticuerpo quimerico o humanizado o fragmento de los mismos que se unen especificamente a por lo menos un epitope en la proteina beta-amiloide; molecula de acido nucleico que lo codifica; composicion que lo comprende; y su uso para tratar enfermedades asociados con la formacion de placas amiloides.
BRPI0512477A (pt) processos para a fabricação de uma polpa de meta- e para-aramida, polpa de meta- e para-aramida, material de fricção e material de vedação
BR112013009153A2 (pt) formulação de ligante de fosfato para dosagem única.
CL2007002620A1 (es) Compuesto marcado con isotopo de fluor; metodo para preparar dicho compuesto; composicion que comprende dicho compuesto; metodo de tomar imagenes de enfermedades que comprende el compuesto antes mencionado; kit que comprende dicho compuesto.
TWI340141B (en) Composition for forming prism layer and prism film manufactured using the same
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
CL2004001473A1 (es) Procedimiento para producir neuronas desde celulas mesenquimatosas no diferenciadas y composicion que las contiene.
CR9853A (es) Compuestos de exemestano (s)-6-metiloxaalquilo y metodos relacionados con su utilizacion
EP1856577A4 (en) POSITIVE DRY FILM PHOTO LACK AND COMPOSITION FOR ITS PRODUCTION
MA31698B1 (fr) Caisse montable, demontable et reutilisable
EP1790336A4 (en) CAPSULE FILM COMPOSITION, CAPSULE FILM, AND CAPSULE COMPRISED THEREFROM
EP1820062A4 (en) DRY FILM PHOTORESIST OF POSITIVE TYPE AND COMPOSITION TO ITS PRODUCTION
JO2675B1 (en) New Association of a sinus node IF current inhibitor and a Calcium inhibitor, and pharmaceutical compositions containing it.
AR067351A1 (es) Combinacion de picotamida con nafronil
GT200400183A (es) Formas de dosificacion de azitromicina con efectos secundarios reducidos
CL2004000084A1 (es) Composicion oral que comprende carbonato de calcio y perlita util para pulir los dientes.
CL2008001746A1 (es) Proceso para la fabricacion de arilmetilsulfonilarenos que comprende hacer reaccionar un arilmetilhaluro con un arilsulfinato de sodio en presencia de una base opcionalmente en presencia de un disolvente; y proceso para la fabricacion de un ligando 3

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 18/02/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/02/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B25G Requested change of headquarter approved

Owner name: MCNEIL-PPC, INC. (US)

B25D Requested change of name of applicant approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25A Requested transfer of rights approved

Owner name: CHENANGO ZERO LLC (US)

B25A Requested transfer of rights approved

Owner name: CHENANGO TWO LLC (US)

B25A Requested transfer of rights approved

Owner name: CURRAHEE HOLDING COMPANY INC. (US)

B25D Requested change of name of applicant approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25A Requested transfer of rights approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25K Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: republication

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

Free format text: RETIFICACAO DO DESPACHO 25.1 PUBLICADO NA RPI 2775 DE 12/03/2024.ONDE SE LE: ?EM ATENDIMENTO AO SOLICITADO NA PETICAO 870230115237 DE 29/12/2023 (...)?LEIA-SE: ?EM ATENDIMENTO AO SOLICITADO NA PETICAO 870230115587 DE 29/12/2023 (...)?

B25D Requested change of name of applicant approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25G Requested change of headquarter approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25D Requested change of name of applicant approved

Owner name: KENVUE BRANDS LLC (US)